MENLO PARK, Calif. & DALLAS--(BUSINESS WIRE)--ReCode Therapeutics, a biopharmaceutical company pioneering disease-modifying genetic medicines using its proprietary LNP delivery platform, presented new ...
In genetic medicines, delivery is key. You want to make sure that the medicine reaches its destination in the body and doesn’t cause any problems along the way. But before that, you want to ensure ...
A biopharmaceutical company that grew out of University of Texas Southwestern Medical Center research in Dallas is attracting another $80 million in funding led by some of Big Pharma's biggest names.
MENLO PARK, Calif. & DALLAS--(BUSINESS WIRE)--ReCode Therapeutics, a biopharmaceutical company pioneering disease-modifying genetic medicines using its proprietary LNP delivery platform, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results